Cargando…

A Novel Substrate Radiotracer for Molecular Imaging of SIRT2 Expression and Activity with Positron Emission Tomography

PURPOSE: The purpose of this study was to develop a SIRT2-specific substrate-type radiotracer for non-invasive PET imaging of epigenetic regulatory processes mediated by SIRT2 in normal and disease tissues. PROCEDURES: A library of compounds containing tert-butyloxycarbonyl-lysineaminomethylcoumarin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonomi, Robin E., Laws, Maxwell, Popov, Vadim, Kamal, Swatabdi, Potukutchi, Shreya, Shavrin, Aleksandr, Lu, Xin, Turkman, Nashaat, Liu, Ren-Shyan, Mangner, Thomas, Gelovani, Juri G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816246/ https://www.ncbi.nlm.nih.gov/pubmed/29423902 http://dx.doi.org/10.1007/s11307-017-1149-8

Ejemplares similares

Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [(18)F]TFAHA
por: Laws, Maxwell T., et al.
Publicado: (2019)

Novel Histone Deacetylase Class IIa Selective Substrate Radiotracers for PET Imaging of Epigenetic Regulation in the Brain
por: Bonomi, Robin, et al.
Publicado: (2015)

Noninvasive quantification of SIRT1 expression–activity and pharmacologic inhibition in a rat model of intracerebral glioma using 2-[(18)F]BzAHA PET/CT/MRI
por: Laws, Maxwell T, et al.
Publicado: (2020)

Low- and high-cocaine intake affects the spatial and temporal dynamics of class IIa HDAC expression-activity in the nucleus accumbens and hippocampus of male rats as measured by [18F]TFAHA PET/CT neuroimaging
por: Perrine, Shane A., et al.
Publicado: (2022)

Novel positron emission tomography radiotracers in brain tumor imaging
por: D’Souza, Maria Mathew, et al.
Publicado: (2011)

Novel late-stage radiosynthesis of 5-[18F]-trifluoromethyl-1,2,4-oxadiazole (TFMO) containing molecules for PET imaging
por: Turkman, Nashaat, et al.
Publicado: (2021)

Design, synthesis, biochemical evaluation, radiolabeling and in vivo imaging with high affinity class-IIa histone deacetylase inhibitor for molecular imaging and targeted therapy
por: Turkman, Nashaat, et al.
Publicado: (2022)

PEG(2000)-DBCO surface coating increases intracellular uptake of liposomes by breast cancer xenografts
por: Liu, Daxing, et al.
Publicado: (2022)

Antibiotic‐Derived Radiotracers for Positron Emission Tomography: Nuclear or “Unclear” Infection Imaging?
por: Gouws, Arno Christiaan, et al.
Publicado: (2022)

Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in Neuroinflammation
por: Hou, Catherine, et al.
Publicado: (2017)

Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production
por: Schopf, Eric, et al.
Publicado: (2018)

Preclinical dosimetry models and the prediction of clinical doses of novel positron emission tomography radiotracers
por: Garrow, Adam A., et al.
Publicado: (2020)

Head-to-head comparison of [(18)F]-fluorodeoxyglucose and [(18)F]-fluorocholine positron emission tomography/computed tomography in three patients with rare gestational trophoblastic neoplasms: A case series
por: Thientunyakit, Tanyaluck, et al.
Publicado: (2019)

Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET)
por: Gomes, Pedro M. O., et al.
Publicado: (2020)

Feasibility of TSPO-Specific Positron Emission Tomography Radiotracer for Evaluating Paracetamol-Induced Liver Injury
por: Kim, Daehee, et al.
Publicado: (2021)

In Silico Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers
por: Graham, Thomas J. A., et al.
Publicado: (2023)

Metabolic Shifts Induced by Fatty Acid Synthase Inhibitor Orlistat in Non-small Cell Lung Carcinoma Cells Provide Novel Pharmacodynamic Biomarkers for Positron Emission Tomography and Magnetic Resonance Spectroscopy
por: Sankaranarayanapillai, Madhuri, et al.
Publicado: (2012)

Fluorine-18 fluorodeoxyglucose positron emission tomography for cardiac sarcoidosis—is it time to consider a new radiotracer?
por: Christopoulos, Georgios, et al.
Publicado: (2017)

Molecular Imaging of Central Dopamine in Obesity: A Qualitative Review across Substrates and Radiotracers
por: Janssen, Lieneke Katharina, et al.
Publicado: (2022)

Basic physics of radiotracers
por: Barnes, W Earl
Publicado: (2017)

Detection of Pancreatic Carcinomas by Imaging Lactose-Binding Protein Expression in Peritumoral Pancreas Using [(18)F]Fluoroethyl-Deoxylactose PET/CT
por: Flores, Leo Garcia, et al.
Publicado: (2009)

Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography
por: Slade, Rozanna L., et al.
Publicado: (2016)

Radiotracer stereochemistry affects substrate affinity and kinetics for improved imaging of system x(C)(-) in tumors
por: Greenwood, Hannah E., et al.
Publicado: (2022)

Lewis Acid-Facilitated Radiofluorination of MN3PU: A LRRK2 Radiotracer
por: Malik, Noeen, et al.
Publicado: (2020)

Radiosynthesis and Evaluation of [(11)C-Carbonyl]-Labeled Carbamates as Fatty Acid Amide Hydrolase Radiotracers for Positron Emission Tomography
por: Wilson, Alan A., et al.
Publicado: (2012)

Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with (18)F-GE-180, a Radiotracer for Translocator Protein (TSPO)
por: Hellberg, Sanna, et al.
Publicado: (2018)

Highly specific noninvasive photoacoustic and positron emission tomography of brain plaque with functionalized croconium dye labeled by a radiotracer
por: Liu, Yajing, et al.
Publicado: (2017)

Positron emission tomography imaging for the assessment of mild traumatic brain injury and chronic traumatic encephalopathy: recent advances in radiotracers
por: Huang, Chu-Xin, et al.
Publicado: (2021)

Gallium-68 Labeling of the Cyclin-Dependent Kinase 4/6 Inhibitors as Positron Emission Tomography Radiotracers for Tumor Imaging
por: Liu, Cheng, et al.
Publicado: (2021)

Radiotracers for the Central Serotoninergic System
por: Mangeant, Reynald, et al.
Publicado: (2022)

High-Contrast PET Imaging with [(18)F]NT160, a Class-IIa Histone Deacetylase Probe for In Vivo Imaging of Epigenetic Machinery in the Central Nervous System
por: Turkman, Nashaat, et al.
Publicado: (2023)

The Synthesis and Evaluations of the (68)Ga-Lissamine Rhodamine B (LRB) as a New Radiotracer for Imaging Tumors by Positron Emission Tomography
por: Li, Xuena, et al.
Publicado: (2016)

Sodium-22-radiolabeled silica nanoparticles as new radiotracer for biomedical applications: in vivo positron emission tomography imaging, biodistribution, and biocompatibility
por: Al Faraj, Achraf, et al.
Publicado: (2015)

Development of a Novel Positron Emission Tomography (PET) Radiotracer Targeting Bromodomain and Extra-Terminal Domain (BET) Family Proteins
por: Bai, Ping, et al.
Publicado: (2020)

A Philosophy for CNS Radiotracer Design
por: Van de Bittner, Genevieve C., et al.
Publicado: (2014)

Current radiotracers to image neurodegenerative diseases
por: Tiepolt, Solveig, et al.
Publicado: (2019)

PET Imaging Radiotracers of Chemokine Receptors
por: Alluri, Santosh R., et al.
Publicado: (2021)

Radiotracers for Bone Marrow Infection Imaging
por: Jødal, Lars, et al.
Publicado: (2021)

Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for Pre-phase I positron emission tomography studies in cancer patients
por: Aboagye, E O, et al.
Publicado: (2002)

Can Gallium-68 Prostate-specific Membrane Antigen Ligand be a Potential Radiotracer for Renal Cortical Positron Emission Tomography Imaging?
por: Sarikaya, Ismet, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g6sul6f2c07u99qo989t3nfd67